Why the study?
What is the extent of information deficits regarding evidence-based disease management in home care patients with diabetes and/or heart failure?
What is the extent of information deficits regarding evidence-based disease management in home care patients with diabetes and/or heart failure?
Significant information deficits exist in home care settings, hindering evidence-based disease management for patients with heart failure and diabetes.
Missing data may impede evidence-based diabetes and HF management in home care; leaves open whether better documentation systems improve outcomes.
A disease management study conducted in home care with 303 patients with diabetes, heart failure, or both revealed information deficits that make disease and quality management difficult. Nurses used a guideline checklist to indicate the amount and type of information available to them on admission and by the end of the episode of care. Nurses reported having data on 7% to 94% of the data elements. Whether a lipid profile had been done, the HbA1C (glycosolated hemoglobin test, also called a hemoglobin A1C) levels, or ejection fractions were known for 7%, 17%, and 18%, respectively. When nurses reported information related to ACE-I use (N = 183), they reported that 76% of patients were on ACE-I (angiotensin-converting enzyme inhibitor) or acceptable alternative for heart failure. But no information was reported on ACE-I use for 12% of the patients (N = 24). Potential solutions to these deficits in information and quality include increased use of guidelines in home care, guideline checklists, information transfer forms, nurse activism to request information, and the adoption of the electronic health record.
No takes yet. Share an insight, caveat, or question.
Bowles et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: